Global Ponatinib Drugs Market Growth 2022-2028
- LP 4850258
- 78 Pages
- February 2022
- Pharmaceuticals
The United States Ponatinib Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Ponatinib Drugs market, reaching US$ million by the year 2028. As for the Europe Ponatinib Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Ponatinib Drugs players cover ARIAD Pharmaceuticals, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Ponatinib Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
45mg
15mg
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
CML
ALL
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
ARIAD Pharmaceuticals
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Ponatinib Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Ponatinib Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Ponatinib Drugs by Country/Region, 2017, 2022 & 2028
2.2 Ponatinib Drugs Segment by Type
2.2.1 45mg
2.2.2 15mg
2.3 Ponatinib Drugs Sales by Type
2.3.1 Global Ponatinib Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Ponatinib Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Ponatinib Drugs Sale Price by Type (2017-2022)
2.4 Ponatinib Drugs Segment by Application
2.4.1 CML
2.4.2 ALL
2.5 Ponatinib Drugs Sales by Application
2.5.1 Global Ponatinib Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Ponatinib Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Ponatinib Drugs Sale Price by Application (2017-2022)
3 Global Ponatinib Drugs by Company
3.1 Global Ponatinib Drugs Breakdown Data by Company
3.1.1 Global Ponatinib Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Ponatinib Drugs Sales Market Share by Company (2020-2022)
3.2 Global Ponatinib Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Ponatinib Drugs Revenue by Company (2020-2022)
3.2.2 Global Ponatinib Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Ponatinib Drugs Sale Price by Company
3.4 Key Manufacturers Ponatinib Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Ponatinib Drugs Product Location Distribution
3.4.2 Players Ponatinib Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Ponatinib Drugs by Geographic Region
4.1 World Historic Ponatinib Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Ponatinib Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Ponatinib Drugs Annual Revenue by Geographic Region
4.2 World Historic Ponatinib Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Ponatinib Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Ponatinib Drugs Annual Revenue by Country/Region
4.3 Americas Ponatinib Drugs Sales Growth
4.4 APAC Ponatinib Drugs Sales Growth
4.5 Europe Ponatinib Drugs Sales Growth
4.6 Middle East & Africa Ponatinib Drugs Sales Growth
5 Americas
5.1 Americas Ponatinib Drugs Sales by Country
5.1.1 Americas Ponatinib Drugs Sales by Country (2017-2022)
5.1.2 Americas Ponatinib Drugs Revenue by Country (2017-2022)
5.2 Americas Ponatinib Drugs Sales by Type
5.3 Americas Ponatinib Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ponatinib Drugs Sales by Region
6.1.1 APAC Ponatinib Drugs Sales by Region (2017-2022)
6.1.2 APAC Ponatinib Drugs Revenue by Region (2017-2022)
6.2 APAC Ponatinib Drugs Sales by Type
6.3 APAC Ponatinib Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Ponatinib Drugs by Country
7.1.1 Europe Ponatinib Drugs Sales by Country (2017-2022)
7.1.2 Europe Ponatinib Drugs Revenue by Country (2017-2022)
7.2 Europe Ponatinib Drugs Sales by Type
7.3 Europe Ponatinib Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Ponatinib Drugs by Country
8.1.1 Middle East & Africa Ponatinib Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Ponatinib Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Ponatinib Drugs Sales by Type
8.3 Middle East & Africa Ponatinib Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ponatinib Drugs
10.3 Manufacturing Process Analysis of Ponatinib Drugs
10.4 Industry Chain Structure of Ponatinib Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Ponatinib Drugs Distributors
11.3 Ponatinib Drugs Customer
12 World Forecast Review for Ponatinib Drugs by Geographic Region
12.1 Global Ponatinib Drugs Market Size Forecast by Region
12.1.1 Global Ponatinib Drugs Forecast by Region (2023-2028)
12.1.2 Global Ponatinib Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Ponatinib Drugs Forecast by Type
12.7 Global Ponatinib Drugs Forecast by Application
13 Key Players Analysis
13.1 ARIAD Pharmaceuticals
13.1.1 ARIAD Pharmaceuticals Company Information
13.1.2 ARIAD Pharmaceuticals Ponatinib Drugs Product Offered
13.1.3 ARIAD Pharmaceuticals Ponatinib Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 ARIAD Pharmaceuticals Main Business Overview
13.1.5 ARIAD Pharmaceuticals Latest Developments
14 Research Findings and Conclusion
Table 1. Ponatinib Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Ponatinib Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 45mg
Table 4. Major Players of 15mg
Table 5. Global Ponatinib Drugs Sales by Type (2017-2022) & (K Units)
Table 6. Global Ponatinib Drugs Sales Market Share by Type (2017-2022)
Table 7. Global Ponatinib Drugs Revenue by Type (2017-2022) & ($ million)
Table 8. Global Ponatinib Drugs Revenue Market Share by Type (2017-2022)
Table 9. Global Ponatinib Drugs Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Ponatinib Drugs Sales by Application (2017-2022) & (K Units)
Table 11. Global Ponatinib Drugs Sales Market Share by Application (2017-2022)
Table 12. Global Ponatinib Drugs Revenue by Application (2017-2022)
Table 13. Global Ponatinib Drugs Revenue Market Share by Application (2017-2022)
Table 14. Global Ponatinib Drugs Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Ponatinib Drugs Sales by Company (2020-2022) & (K Units)
Table 16. Global Ponatinib Drugs Sales Market Share by Company (2020-2022)
Table 17. Global Ponatinib Drugs Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Ponatinib Drugs Revenue Market Share by Company (2020-2022)
Table 19. Global Ponatinib Drugs Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Ponatinib Drugs Producing Area Distribution and Sales Area
Table 21. Players Ponatinib Drugs Products Offered
Table 22. Ponatinib Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Ponatinib Drugs Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Ponatinib Drugs Sales Market Share Geographic Region (2017-2022)
Table 27. Global Ponatinib Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Ponatinib Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Ponatinib Drugs Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Ponatinib Drugs Sales Market Share by Country/Region (2017-2022)
Table 31. Global Ponatinib Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Ponatinib Drugs Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Ponatinib Drugs Sales by Country (2017-2022) & (K Units)
Table 34. Americas Ponatinib Drugs Sales Market Share by Country (2017-2022)
Table 35. Americas Ponatinib Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Ponatinib Drugs Revenue Market Share by Country (2017-2022)
Table 37. Americas Ponatinib Drugs Sales by Type (2017-2022) & (K Units)
Table 38. Americas Ponatinib Drugs Sales Market Share by Type (2017-2022)
Table 39. Americas Ponatinib Drugs Sales by Application (2017-2022) & (K Units)
Table 40. Americas Ponatinib Drugs Sales Market Share by Application (2017-2022)
Table 41. APAC Ponatinib Drugs Sales by Region (2017-2022) & (K Units)
Table 42. APAC Ponatinib Drugs Sales Market Share by Region (2017-2022)
Table 43. APAC Ponatinib Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Ponatinib Drugs Revenue Market Share by Region (2017-2022)
Table 45. APAC Ponatinib Drugs Sales by Type (2017-2022) & (K Units)
Table 46. APAC Ponatinib Drugs Sales Market Share by Type (2017-2022)
Table 47. APAC Ponatinib Drugs Sales by Application (2017-2022) & (K Units)
Table 48. APAC Ponatinib Drugs Sales Market Share by Application (2017-2022)
Table 49. Europe Ponatinib Drugs Sales by Country (2017-2022) & (K Units)
Table 50. Europe Ponatinib Drugs Sales Market Share by Country (2017-2022)
Table 51. Europe Ponatinib Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Ponatinib Drugs Revenue Market Share by Country (2017-2022)
Table 53. Europe Ponatinib Drugs Sales by Type (2017-2022) & (K Units)
Table 54. Europe Ponatinib Drugs Sales Market Share by Type (2017-2022)
Table 55. Europe Ponatinib Drugs Sales by Application (2017-2022) & (K Units)
Table 56. Europe Ponatinib Drugs Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Ponatinib Drugs Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Ponatinib Drugs Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Ponatinib Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Ponatinib Drugs Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Ponatinib Drugs Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Ponatinib Drugs Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Ponatinib Drugs Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Ponatinib Drugs Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Ponatinib Drugs
Table 66. Key Market Challenges & Risks of Ponatinib Drugs
Table 67. Key Industry Trends of Ponatinib Drugs
Table 68. Ponatinib Drugs Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Ponatinib Drugs Distributors List
Table 71. Ponatinib Drugs Customer List
Table 72. Global Ponatinib Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Ponatinib Drugs Sales Market Forecast by Region
Table 74. Global Ponatinib Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Ponatinib Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Ponatinib Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Ponatinib Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Ponatinib Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Ponatinib Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Ponatinib Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Ponatinib Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Ponatinib Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Ponatinib Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Ponatinib Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Ponatinib Drugs Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Ponatinib Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Ponatinib Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Ponatinib Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Ponatinib Drugs Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Ponatinib Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Ponatinib Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 92. ARIAD Pharmaceuticals Basic Information, Ponatinib Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. ARIAD Pharmaceuticals Ponatinib Drugs Product Offered
Table 94. ARIAD Pharmaceuticals Ponatinib Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. ARIAD Pharmaceuticals Main Business
Table 96. ARIAD Pharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Ponatinib Drugs
Figure 2. Ponatinib Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Ponatinib Drugs Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Ponatinib Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Ponatinib Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 45mg
Figure 10. Product Picture of 15mg
Figure 11. Global Ponatinib Drugs Sales Market Share by Type in 2021
Figure 12. Global Ponatinib Drugs Revenue Market Share by Type (2017-2022)
Figure 13. Ponatinib Drugs Consumed in CML
Figure 14. Global Ponatinib Drugs Market: CML (2017-2022) & (K Units)
Figure 15. Ponatinib Drugs Consumed in ALL
Figure 16. Global Ponatinib Drugs Market: ALL (2017-2022) & (K Units)
Figure 17. Global Ponatinib Drugs Sales Market Share by Application (2017-2022)
Figure 18. Global Ponatinib Drugs Revenue Market Share by Application in 2021
Figure 19. Ponatinib Drugs Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Ponatinib Drugs Revenue Market Share by Company in 2021
Figure 21. Global Ponatinib Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Ponatinib Drugs Revenue Market Share by Geographic Region in 2021
Figure 23. Global Ponatinib Drugs Sales Market Share by Region (2017-2022)
Figure 24. Global Ponatinib Drugs Revenue Market Share by Country/Region in 2021
Figure 25. Americas Ponatinib Drugs Sales 2017-2022 (K Units)
Figure 26. Americas Ponatinib Drugs Revenue 2017-2022 ($ Millions)
Figure 27. APAC Ponatinib Drugs Sales 2017-2022 (K Units)
Figure 28. APAC Ponatinib Drugs Revenue 2017-2022 ($ Millions)
Figure 29. Europe Ponatinib Drugs Sales 2017-2022 (K Units)
Figure 30. Europe Ponatinib Drugs Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Ponatinib Drugs Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Ponatinib Drugs Revenue 2017-2022 ($ Millions)
Figure 33. Americas Ponatinib Drugs Sales Market Share by Country in 2021
Figure 34. Americas Ponatinib Drugs Revenue Market Share by Country in 2021
Figure 35. United States Ponatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Ponatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Ponatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Ponatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Ponatinib Drugs Sales Market Share by Region in 2021
Figure 40. APAC Ponatinib Drugs Revenue Market Share by Regions in 2021
Figure 41. China Ponatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Ponatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Ponatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Ponatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Ponatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Ponatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Ponatinib Drugs Sales Market Share by Country in 2021
Figure 48. Europe Ponatinib Drugs Revenue Market Share by Country in 2021
Figure 49. Germany Ponatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Ponatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Ponatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Ponatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Ponatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Ponatinib Drugs Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Ponatinib Drugs Revenue Market Share by Country in 2021
Figure 56. Egypt Ponatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Ponatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Ponatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Ponatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Ponatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Ponatinib Drugs in 2021
Figure 62. Manufacturing Process Analysis of Ponatinib Drugs
Figure 63. Industry Chain Structure of Ponatinib Drugs
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
